"The Report Global Bio CMO
Market: Size, Trends & Forecasts (2016-2021) provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Scope of the Report
The
report entitled Global Bio CMO Market: Size, Trends & Forecasts
(2016-2021), provides analysis of the global bio CMO market, with
detailed analysis of market size and growth, penetration, market
share and economic impact of the industry. The report also provides
the analysis of the global biologics market by value, by top selling
products, etc.
Furthermore,
the report also assesses the key opportunities in the market and
outlines the factors that are and will be driving the growth of the
industry. Growth of the overall global bio CMO market has been
forecasted for the years 2016-2021, taking into consideration the
previous growth pattern, the growth drivers and the current and
future trends.
View
Report @ http://www.marketresearchreports.biz/analysis/948217
Lonza,
Boehringer Ingelheim, Samsung Biologics are key companies in the
global bio CMO market. The company profiling of these companies has
been done in the report, which includes business overview, financial
overview and respective business strategies of the companies.
Company
Coverage
Lonza
Boehringer
Ingelheim
Samsung
Electronics (Samsung Biologics)
Get
Sample Copy Of This Report @
Executive
Summary
Pharmaceutical
industry comprise of discovering, developing, producing and marketing
of drugs for medical use. Worlds largest pharmaceutical firms are
located in the North America, Europe and Japan. On the basis of
technological platform, pharmaceutical drugs can be divided into
small molecule or conventional drugs and large molecule or biologic
drugs.
Biologics
are made through biological processes and are generally injected.
Biologics comprises of vaccines, blood or blood components, somatic
cells, gene therapy, etc. Biologics are categorized into first-or
second generation, depending on development period and cell line.
Biosimilars are the biological that are similar, but not identical to
the original product.
CMO
or Contract Manufacturing Organization is a third party, which the
pharmaceutical firms approach for the manufacturing of components of
its product or whole of its product. Bio CMOs are typically used to
provide secondary manufacturing coverage for the branded
pharmaceutical industry. On the basis of production technology, bio
CMOs can be divided into mammalian cell system and microbial system.
The
global bio CMO market is expected to increase at a significant growth
rate during the forecasted period (2016-2021). The global bio CMO
market is supported by various growth drivers, such as increase in
pharmaceutical industry, growth in use of biosimilars, potential
biologics blockbusters, etc. Yet, the market faces certain
challenges, such as risk associated with CMOs, presence of in-house
manufacturing facilities of big pharma companies, productivity issues
with mammalian cell system, etc.
Table of Contents
1. Executive Summary
2. Introduction
2.1 Pharmaceutical Industry
Overview
2.1.1 Segments of Pharmaceutical
Industry (Drugs)
2.2 Biotechnology/Biologics
Overview
2.3 Biosimilar Overview
2.4 Biologics/ Biosimilar
Manufacturing
2.5 Bio CMO Overview
3. Global Market Analysis
3.1 Global Biologics Market: An
Analysis
3.1.1 Global Biologics Market by
Value
3.1.2 Global Biologics Market by
Top Selling Drugs
3.1.3 Global Biologics Market by
Product in Development
3.1.4 Global Biologics
Manufacturing market by Value
3.2 Global Bio CMO Market: An
Analysis
3.2.1 Global Bio CMO Market by
Penetration Rate
3.2.2 Global Bio CMO Market by
Value
3.2.3 Global Bio CMO Market by
Capacity
3.2.4 Global Bio CMO Market by
Segments
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Global Pharmaceutical Market
Growth
4.1.2 Potential Biologics
Blockbusters
4.1.3 Increase in Biosimilar
Market
4.1.4 Preference of Biologics Over
Small Molecules
4.2 Challenges
4.2.1 Presence for In-House
Biopharma Manufacturing
4.2.2 Risk Associated with CMOs
4.2.3 Productivity Issue with
Mammalian Cell System
4.3 Market Trends
4.3.1 Big Pharmaceuticals
Outsourcing Rate
4.3.2 Capacity Utilization Rate of
CMOs
4.3.3 Growth in Mammalian Cell
Structure
4.3.4 Stringent Regulatory
Requirements for Biologics and Biosimilars
5. Competitive Landscape
5.1 Global Bio CMO Market by
Number of Firms
5.2 Global Bio CMO Market Players
by Capacity
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment